WO2025052180 - LIPIDS AND LIPID NANOPARTICLES
National phase entry is expected:
Publication Number
WO/2025/052180
Publication Date
13.03.2025
International Application No.
PCT/IB2024/000526
International Filing Date
09.09.2024
Title **
[English]
LIPIDS AND LIPID NANOPARTICLES
[French]
LIPIDES ET NANOPARTICULES LIPIDIQUES
Applicants **
AXELYF EHF.
Inventors
ALMARSSON, Örn
LUCAS, John
Priority Data
63/536,997
07.09.2023
US
63/664,820
27.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4131 | |
| EPO | Filing, Examination, Granting | 28762 | |
| Japan | Filing, Examination, Granting | 3143 | |
| South Korea | Filing, Examination, Granting | 4116 | |
| USA | Filing, Examination, Granting | 12240 |
Total:
52,392
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides for lipids that may be formulated in a delivery vehicle to facilitate the encapsulation of a wide range of payloads including therapeutic and diagnostic agents, such as, without limitation, nucleic acids (e.g., RNA or DNA), proteins, peptides, and small molecule active pharmaceutical ingredients (APIs).[French]
La présente invention concerne des lipides qui peuvent être formulés dans un véhicule d'administration pour permettre l'encapsulation d'une large gamme de charges utiles comprenant des agents thérapeutiques et diagnostiques, tels que, sans limitation, des acides nucléiques (par exemple, ARN ou ADN), des protéines, des peptides et des ingrédients pharmaceutiques actifs (API) à petites molécules.